Sustained steroid release in pulmonary inflammation model
- 31 August 2010
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 31 (23), 6050-6059
- https://doi.org/10.1016/j.biomaterials.2010.04.025
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Recent Advances in Controlled Release Pulmonary TherapyCurrent Drug Delivery, 2009
- Advances in treating acute asthma exacerbations in childrenCurrent Opinion in Pediatrics, 2009
- Particle Engineering for Pulmonary Drug DeliveryPharmaceutical Research, 2007
- Micron‐Size Drug Particles: Common and Novel Micronization TechniquesPharmaceutical Development and Technology, 2004
- Alternative sugars as potential carriers for dry powder inhalationsInternational Journal of Pharmaceutics, 2003
- Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at nightJournal of Allergy and Clinical Immunology, 1999
- A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose phthalate nanospheres.Pharmaceutical Research, 1998
- Inhaled Glucocorticoids for AsthmaThe New England Journal of Medicine, 1995
- Four-times-a-day Dosing Frequency Is Better than a Twice-a-day Regimen in Subjects Requiring a High-dose Inhaled Steroid, Budesonide, to Control Moderate to Severe AsthmaAmerican Review of Respiratory Disease, 1989
- Prediction of Drug Residence Times in Regions of the Human Respiratory Tract Following Aerosol InhalationJournal of Pharmaceutical Sciences, 1986